Resources for Healthcare Professionals and Patients

The use of COVID‑19 Vaccine Moderna is permitted under an interim authorization delivered in accordance with section 5 of the COVID‑19 Interim Order (IO). Patients should be advised of the nature of the authorization. The interim authorization is associated with Terms and Conditions that need to be met by the Market Authorization Holder to ascertain the continued quality, safety and efficacy of the product. For further information on authorization under this pathway, please refer to Health Canada’s IO Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID‑19.

The current COVID‑19 Vaccine Moderna vial and carton labels are not Canadian-specific as global, English-only labels are being used for the Canadian market.

For more information, please see the Health Product Risk Communication.

COVID‑19 Vaccine Moderna (mRNA‑1273 SARS‑CoV‑2 vaccine) is indicated for active immunization against coronavirus disease 2019 (COVID‑19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) virus in individuals 18 years of age and older.

Please find helpful resources for COVID‑19 Vaccine Moderna below. Check back as we update with additional educational content as it becomes available.

Drug Identification Number (DIN): 02510014

Patient Medication


Storage, Handling, Dosage
and Administration

Health Product Risk Communication

2nd Dose Reminder Card

Reporting Adverse Events

Managing marketed health product-related side effects depends on healthcare professionals and patients reporting them. Any serious or unexpected side effects in patients receiving COVID‑19 Vaccine Moderna should be reported to your local Health Unit.

If a patient experiences a side effect following immunization, please complete the Adverse Events Following Immunization (AEFI) Form appropriate for your province/territory and send it to your local Health Unit.

In addition, you can report side effects to Moderna at 1-866-MODERNA (1-866-663-3762).

Product Concerns

All designated vaccination sites need to maintain security around the storage of COVID‑19 Vaccine Moderna within their facilities.

Make sure that vials of COVID‑19 Vaccine Moderna arrive and are stored in their original packaging. If you suspect that the COVID‑19 Vaccine Moderna you have purchased may be counterfeit, if there are any irregularities with packaging, and/or with the arrival of the shipments, please contact us at 1‑866‑663‑3762 or visit, or report a complaint to Health Canada.